Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma is a research paper published in Neuro-Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 NS113854
Department of Defense Investigator Initiated Research Award
Grant: W81XWH-20-1-0222
Clinical Research Award
Grant: W81XWH2210439
American Cancer Society Mission Boost
Grant: MBGI-21-185-01-MBG
Children’s Tumor Foundation Drug Discovery Initiative award
FWCI
1.57
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals